Moreover, the chemokine CCL22, fundamental in the FL milieu, decreases after idelalisib treatment, and this phenomenon impacts on the composition of FL microenvironment by a decrease in the recruitment of TREG and TFH, but not TFR into FL-FDC niche, which may allow the host to mount superior immune responses against the tumor [60]. Here, CCL22 is linked to neoplasm.